Article
Dissecting PON1 Genotype Combinations Modulating Paraoxonase Activity and Risk of Dysglycemia and Liver Fibrosis
2026-04-10
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background & Aims</h4> Metabolic disorders such as dyslipidemia, metabolic dysfunction–associated steatotic liver disease (MASLD), and diabetes are promoted by chronic pro-inflammatory and pro-oxidative states. Paraoxonase 1 (PON1), a liver-derived HDL-associated enzyme, plays an important antioxidant role by hydrolyzing oxidized lipids and protecting against oxidative stress– induced damag...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6996e518-97cb-5619-b7f5-0ce0629e717f
- DOI
- 10.64898/2026.04.09.26350501
